Un buen precio.  en línea

Detalles de los productos

Created with Pixso. En casa Created with Pixso. Productos Created with Pixso.
Medicamentos para el cáncer de mama
Created with Pixso. Palbociclib Capsules 125mg 21 Capsules Box Standard Dose CDK4 6 Inhibitor First Line Endocrine Therapy Advanced Breast Cancer

Palbociclib Capsules 125mg 21 Capsules Box Standard Dose CDK4 6 Inhibitor First Line Endocrine Therapy Advanced Breast Cancer

Nombre De La Marca: Sichuan Kelun Pharmaceutical Co., Ltd.
Número De Modelo: Palbociclib KL-20223934
Cantidad Mínima De Pedido: Negociable
Precio: Please contact a specialist WhatsApp:55342706
El Tiempo De Entrega: Negociable
Condiciones De Pago: Western Union, MoneyGram, T/T
Información detallada
Lugar de origen:
Chengdú, Sichuan, China
Certificación:
NMPA/GMP
Detalles de empaquetado:
Negociable
Capacidad de la fuente:
Negociable
Resaltar:

Standard Dose CDK4 6 Inhibitor

,

First Line Metastatic Breast Cancer

,

Palbociclib Letrozole Combination

Descripción del Producto
Palbociclib 125mg x 21 Capsules [Product Name] Generic Name: Palbociclib Brand Name: Pailunxin Specification: 125mg x 21 Capsules [Active Ingredient] Palbociclib [Indications] HR+/HER2- advanced/metastatic breast cancer: first-line with aromatase inhibitor; post-endocrine with fulvestrant. Standard starting dose. [Mechanism of Action] First-in-class highly selective CDK4/6 inhibitor. Prevents Rb phosphorylation, inducing G1 cell cycle arrest. [Dosage] 125mg daily with food,